Skip to main content

UBS Group AG

Position in PCSA — Processa Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in PCSA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,964
+$8,574 QoQ
Shares Held
7,794
+207.9% QoQ
Ownership
0.279%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 12 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. PCSA ranks #437 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCSA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,964 7,794
2026-03-31 $6,390 2,531
2025-12-31 $36,402 12,640
2025-06-30 $13,245 64,612
2025-03-31 $20 56
2024-12-31 $6,990 7,908
2024-09-30 $713 521
2024-03-31 $9,888 4,181
2023-12-31 $26,807 80,023
2023-09-30 $176 707
2023-03-31 $11,229 22,459
2022-03-31 $3,356 1,115
2021-12-31 $1,068 218
2021-09-30 $4,679 546
2021-06-30 $343 42